Access
To read this story in full you will need to login or make a payment (see right).
Editorial
Nature Medicine 15, 463 - 464 (2009)
doi:10.1038/nm0509-463
A really serious conflict
Abstract
Not all financial interests in drug discovery are detrimental, and many are essential for its success. But focusing on perceived conflicts of interest may cause true scientific corruption to go unnoticed.
Transforming a laboratory finding into a new medicine involves numerous steps and stakeholders. In a simple case, a researcher discovers and publishes a new target, and an academic or industrial organization decides to commercialize it.
To read this story in full you will need to login or make a payment (see right).
